Skip to main content
. 2020 Nov 3;12(11):3238. doi: 10.3390/cancers12113238

Figure 4.

Figure 4

Immune characteristics of FAP status-defined subgroups of CD8a density-high cases in the U-CAN population. (A) Total tumor densities and ratio of the epithelial-to-stromal density of immune markers in the FAP intensity-defined cases. (B) FoxP3 density in the FAP intensity-defined groups within the CD8a density-high cases. (C) The ratio of epithelial-to-stromal density of CD8a density cells in the FAP-defined groups within the CD8a density-high cases.